Increasing disparities in breast cancer mortality from 1979 to 2010 for US black women aged 20 to 49 years

American Journal of Public Health

Volumn 105, Issue , 2015, Pages S446-S448

  McCarthy, Anne Marie ^a   Yang, Jianing ^b   Armstrong, Katrina ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; BREAST TUMOR; CAUCASIAN; CAUSE OF DEATH; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HEALTH DISPARITY; HUMAN; MIDDLE AGED; MORTALITY; TRENDS; UNITED STATES;

ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; CAUSE OF DEATH; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MIDDLE AGED; MORTALITY; UNITED STATES;

EID: 84937509191     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302297     Document Type: Article

References (25)

1. Howlader NNA, Krapcho M, Garshell J, et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014.
2. Ekwueme DU, Guy GP Jr, Rim SH, et al. Health and economic impact of breast cancer mortality in young women, 1970-2008. Am J Prev Med. 2014;46(1):71-79.
3. Quinn J. A unique approach to performance standards for clinicians in a CMHC. J Ment Health Adm. 1984;11(2):31-32.
4. Krieger N, Chen JT, Coull BA, Beckfield J, Kiang MV, Waterman PD. Jim Crow and premature mortality among the US Black and White population, 1960-2009: an ageperiod-cohort analysis. Epidemiology. 2014;25(4):494-504.
5. Williams DR, Mohammed SA, Leavell J, Collins C. Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci. 2010;1186:69-101.
6. Quinn GE. Screening and outcome of retinopathy of prematurity. Curr Opin Ophthalmol. 1994;5(3):66-71.
7. Quinn J. Elder care: the employee benefit of the 1990s? J Health Care Benefits. 1994;3(4):41-44.
8. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1980.
9. International Classification of Diseases, 10th Revision. Geneva, Switzerland: World Health Organization; 1992.
10. Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49(2):1-32.
11. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541-553.
12. Miller JW, King JB, Joseph DA, Richardson LC, Centers for Disease Control and Prevention. Breast cancer screening among adult women-Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(suppl):46-50.
13. Block LD, Jarlenski MP, Wu AW, Bennett WL. Mammography use among women ages 40-49 after the 2009 U. S. Preventive Services Task Force recommendation. J Gen Intern Med. 2013;28(11):1447-1453.
14. Scharpf TP, Rimm AA. Mammography utilization rates among young White and Black women in the USA. Public Health. 2006;120(10):937-941.
15. Kapp JM, Ryerson AB, Coughlin SS, Thompson TD. Racial and ethnic differences in mammography use among U. S. women younger than age 40. Breast Cancer Res Treat. 2009;113(2):327-337.
16. Clarke CA, Keegan TH, Yang J, et al. Age-specific incidence of breast cancer subtypes: understanding the Black-White crossover. J Natl Cancer Inst. 2012;104 (14):1094-1101.
17. Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations. Cancer. 2011;117(12):2747-2753.
18. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-2502.
19. Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012;188(2):391-397.
20. Howlader N, Altekruse SF, Li CI, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014; 106(5):dju055.
21. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334-357.
22. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101 (14):984-992.
23. Balasubramanian BA, Demissie K, Crabtree BF, Strickland PA, Pawlish K, Rhoads GG. Black Medicaid beneficiaries experience breast cancer treatment delays more frequently than Whites. Ethn Dis. 2012;22(3): 288-294.
24. Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res. 2010;12(5):212.
25. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009; 36(3):237-249.